跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
全泽复 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Cefdinir Capsules
Approved
化学药品
Cefdinir Capsules
LTL PHARMA CO., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Apr 23, 2020
Approval ID
7LeagVeuiKG
Company
LTL PHARMA CO., LTD.
Type
化学药品
Approval Details
Approval Id
7LeagVeuiKG
Approval Number
国药准字J20170014
Generic Name
头孢地尼胶囊
Generic Name En
Cefdinir Capsules
Trade Name
全泽复
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.1g(按C14H13N5O5S2计算)
Reg Date
2020-04-23
Company Name
LTL PHARMA CO., LTD.
Company Address
Nittochi Nishi-shinjuku Bldg. 13F, 6-10-1, Nishi-shinjuku, Shinjuku-ku, Tokyo 160-0023,Japan
Production Company Name
choseido pharmaceutical co.,ltd. kawauchi factory
Production Company Address
463. Kagasuno, Kawauchi-cho, Tokushima-City, Tokushima, 771-0130, Japan
Company Detail Path
/organization/ltl-pharma-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 23, 2020
Approval ID
7LeagVeuiKG
Type
化学药品
Back to NMPA Approvals